Drug Database
Back to search

France· FR:61670321

MYRELEZ L.P. 120 mg, solution injectable à libération prolongée en seringue préremplie

A lanreotide product containing acétate de lanréotide, registered in France by AMDIPHARM, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC H01CB03

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedMYRELEZ L.P. 120 mg, solution injecta…ATCH01CB03REGISTER NO.FR:61670321PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about acétate de lanréotideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lanreotide is registered in 17 of 19 countries.

Countries holding a registration under ATC H01CB03 (lanreotide), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 10 of them publish a price we can compare per daily dose
Search lanreotide products by name

Lanreotide · ATC H01CB03

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of lanreotide costs, country by country.

Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.

  • France: $53.80 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Lanreotide · price per daily dose (3 mg)

USD · FX 28 Sept 2026

  • FR France$53.80
  • CH Switzerland$44.46
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
ACÉTATE DE LANRÉOTIDE
Manufacturer
AMDIPHARM
Country
France (FR)
ATC code
H01CB03
ATC class
Lanreotide
Defined daily dose
3 mg, P
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930228364
    1 seringue préremplie polypropylène de 0,5 ml avec aiguille(s) avec système de sécurité automatique
    EUR 659.5

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

157 interactions on record for lanreotide.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check lanreotide against other medicinesHow interaction checks work

Lanreotide · interactions on record

157 records

  • 2 severe
  • 151 moderate
  • 4 minor

Most severe, free to view

  • LonafarnibA16AX20severe
  • PexidartinibL01EX15severe
  • LiraglutidA08AX02moderate
  • SemaglutidA08AX03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lanreotide in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lanreotide products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Lanreotid Sun Pharma, Lanreotid Viatris
  • Belgium · Lanreotide Sun, Lanreotide Viatris
  • Cyprus · Somatuline Autogel
  • Czechia · Lanreotid Sun, Lanreotid Zentiva
  • Germany · Lanreotid Sun, Lanreotid Viatris
  • Denmark · Ipstyl Autogel, Lanreotid Amdipharm Limited
  • Estonia · Myrelez, Somatuline Autogel
  • Spain · Lanreotida Sun, Lanreotida Zentiva
  • Finland · Lanreotid Sun, Lanreotid Zentiva
  • United Kingdom (Northern Ireland) · Lanreotide Mylan, Lanreotide Zentiva
  • Greece · Lanrod, Myrelez
  • Hungary · Lanreotid Sun, Somatuline Autogel
  • Ireland · Lanreotide Sun, Lanreotide Viatris
  • Italy · Ipstyl, Lanrenet
  • Lithuania · Myrelez, Somatuline Autogel
  • Luxembourg · Somatuline Autogel Injectable, Somatuline Autogel Injectable120
  • Latvia · Myrelez, Somatuline Autogel
  • Netherlands · Lanreotide Sun, Mytolac
  • Norway · Ipstyl Autogel, Lanreotid Sun
  • Poland · Lanreotide Zentiva, Myrelez
  • Portugal · Myrelez, Somatulina Autogel
  • Romania · Lanreotidă Terapia, Lanreotidă Zentiva
  • Sweden · Lanreotid Amdipharm, Lanreotid Sun
  • Slovenia · Somatuline Autogel
  • Slovakia · Lanreotid Sun, Lanreotid Zentiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/050464b9-d10c-4b36-b81b-917dd5274644
GET /v1/drugs/050464b9-d10c-4b36-b81b-917dd5274644?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61670321",
  "date_amm": "2021-04-15",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "ACÉTATE DE LANRÉOTIDE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable à libération prolongée",
  "voies_administration": "sous-cutanée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about lanreotide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console